Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0001
Source ID: NCT03682952
Associated Drug: Alprostadil Injection
Title: Evaluation of Nail Fold Microcirculation in CKD
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Chronic Renal Disease
Interventions: DRUG: Alprostadil Injection|DRUG: Beraprost sodium tablets
Outcome Measures: Primary: Nailfold microcirculation morphological integral, Nail fold capillary microscopy examination, Up to three and a half months|Nailfold microcirculation blood flow integral, Nail fold capillary microscopy examination, Up to three and a half months|Nail fold microcirculation perivascular loop integral, Nail fold capillary microscopy examination, Up to three and a half months | Secondary: The content of blood serum creatinine, Intravenous blood sampling, Up to three and a half months|The content of blood urea nitrogen, Intravenous blood sampling,uronoscopy, Up to three and a half months|The content of blood cystatin C, Intravenous blood sampling, Up to three and a half months|eGFR, Intravenous blood sampling, Up to three and a half months|The content of blood albumin, Intravenous blood sampling, Up to three and a half months|The quantification of urinary protein, Uronoscopy, Up to three and a half months|The content of hemoglobin, Intravenous blood sampling, Up to three and a half months
Sponsor/Collaborators: Sponsor: The Affiliated Hospital of Xuzhou Medical University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 100
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Start Date: 2018-02-01
Completion Date: 2019-04-30
Results First Posted:
Last Update Posted: 2018-09-26
Locations: The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China
URL: https://clinicaltrials.gov/show/NCT03682952